Scalper1 News
Medical device maker Edwards Lifesciences (EW) jumped 11% to an all-time high in the stock market today after it beat Q3 earnings estimates late Thursday and got a barrage of price-target increases from analysts. Edwards’ earnings rose 14% over the year-earlier quarter to 80 cents a share, beating analysts’ consensus by 8 cents. Sales increased 23% to $607 million, more than $60 million above the Street’s average estimate. For the fourth quarter, Scalper1 News
Scalper1 News